SB333 (2018) Detail

Relative to pharmacy interns and vaccinations.


CHAPTER 104

SB 333 - FINAL VERSION

 

 

2018 SESSION

18-2726

10/03

 

SENATE BILL 333

 

AN ACT relative to pharmacy interns and vaccinations.

 

SPONSORS: Sen. Soucy, Dist 18; Sen. Bradley, Dist 3; Sen. Reagan, Dist 17; Rep. P. Schmidt, Straf. 19; Rep. M. MacKay, Hills. 30; Rep. LeBrun, Hills. 32; Rep. M. Pearson, Rock. 34; Rep. Guthrie, Rock. 13

 

COMMITTEE: Health and Human Services

 

-----------------------------------------------------------------

 

ANALYSIS

 

This bill allows a pharmacy intern under the supervision of a pharmacist to administer hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccines.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

18-2726

10/03

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Eighteen

 

AN ACT relative to pharmacy interns and vaccinations.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

104:1  Pharmacist Administration of Vaccines; Pharmacy Interns Added.  Amend RSA 318:16-d to read as follows:

318:16-d  Pharmacist Administration of Additional Vaccines.  In addition to the authority under RSA 318:16-b, a pharmacist or pharmacy intern under the direct supervision of an immunizing pharmacist may administer hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccines to individuals 18 years of age or older, provided all of the criteria in this section have been met.  The pharmacist and pharmacy intern shall:

I.  Hold a current license to practice as a pharmacist in New Hampshire or be registered as a pharmacy intern under RSA 318:15-b in New Hampshire.

II.  Possess at least $1,000,000 of professional liability insurance coverage.

III.  In order to administer hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccines, have completed training specific to the administering of the respective vaccines that includes programs approved by the Accreditation Council for Pharmacy Education (ACPE) or curriculum-based programs from an ACPE-accredited college of pharmacy or state or local health department programs or programs recognized by the board.

IV.  Provide to the board evidence of compliance with paragraphs I-III.

V.  Provide notice to the primary care provider, when designated by the patient, of the administration of the hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccines.

VI.  Maintain a record of administration of hepatitis A, hepatitis B, Tdap, MMR, and meningococcal vaccinations for each individual as required by state and federal law.

104:2  Effective Date.  This act shall take effect 60 days after its passage.

 

Approved: May 25, 2018

Effective Date: July 24, 2018

Links


Date Body Type
Jan. 9, 2018 Senate Hearing
Jan. 9, 2018 Senate Hearing
Jan. 18, 2018 Senate Floor Vote
April 3, 2018 House Hearing
April 3, 2018 House Exec Session
House Floor Vote
April 12, 2018 House Floor Vote

Bill Text Revisions

SB333 Revision: 4024 Date: May 30, 2018, 2:06 p.m.
SB333 Revision: 3460 Date: April 13, 2018, 9:03 a.m.
SB333 Revision: 2690 Date: Dec. 8, 2017, 11:56 a.m.

Docket


May 25, 2018: Signed by the Governor on 05/25/2018; Chapter 0104; Effective 07/24/2018


April 26, 2018: Enrolled (In recess 04/26/2018); SJ 15


April 26, 2018: Enrolled 04/26/2018


April 12, 2018: Ought to Pass: MA VV 04/12/2018 HJ 12 P. 6


: Committee Report: Ought to Pass (Vote 15-1; CC)


April 12, 2018: Committee Report: Ought to Pass for 04/12/2018 (Vote 15-1; CC) HC 14 P. 5


April 3, 2018: Executive Session: 04/03/2018 LOB 205


April 3, 2018: Public Hearing: 04/03/2018 10:00 AM LOB 205


March 7, 2018: Introduced 03/07/2018 and referred to Health, Human Services and Elderly Affairs HJ 7 P. 50


Jan. 18, 2018: Ought to Pass: MA, VV; OT3rdg; 01/18/2018; SJ 2


Jan. 18, 2018: Committee Report: Ought to Pass, 01/18/2018; SC 3


Jan. 9, 2018: Hearing: 01/09/2018, Room 101, LOB, 01:20 pm, on proposed amendment # 2018-0041s; SC 2A


Jan. 9, 2018: Hearing: 01/09/2018, Room 101, LOB, 01:15 pm; SC 48


Jan. 3, 2018: To Be Introduced 01/03/2018 and Referred to Health and Human Services; SJ 1